ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
564 hedge funds and large institutions have $33.4B invested in Alexion Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 240 increasing their positions, 194 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
6% less capital invested
Capital invested by funds: $35.6B → $33.4B (-$2.15B)
61% less funds holding in top 10
Funds holding in top 10: 18 → 7 (-11)
Holders
564
Holding in Top 10
7
Calls
$121M
Puts
$129M
Top Buyers
| 1 | +$329M | |
| 2 | +$155M | |
| 3 | +$117M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$106M |
| 5 |
Millennium Management
New York
|
+$97.7M |
Top Sellers
| 1 | -$428M | |
| 2 | -$238M | |
| 3 | -$174M | |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$122M |
| 5 |
DCP
DSM Capital Partners
Palm Beach Gardens,
Florida
|
-$113M |